{"id":"https://openalex.org/W2899834042","doi":"https://doi.org/10.1093/neuonc/noy148.314","title":"DRES-07. DEFINING THE MECHANISMS OF ACQUIRED RESISTANCE TO TYROSINE KINASE INHIBITORS IN EGFR-DRIVEN GLIOBLASTOMAS USING INTEGRATED KINOME AND TRANSCRIPTOME PROFILING","display_name":"DRES-07. DEFINING THE MECHANISMS OF ACQUIRED RESISTANCE TO TYROSINE KINASE INHIBITORS IN EGFR-DRIVEN GLIOBLASTOMAS USING INTEGRATED KINOME AND TRANSCRIPTOME PROFILING","publication_year":2018,"publication_date":"2018-11-01","ids":{"openalex":"https://openalex.org/W2899834042","doi":"https://doi.org/10.1093/neuonc/noy148.314","mag":"2899834042"},"language":"en","primary_location":{"id":"doi:10.1093/neuonc/noy148.314","doi":"https://doi.org/10.1093/neuonc/noy148.314","is_oa":true,"landing_page_url":"https://doi.org/10.1093/neuonc/noy148.314","pdf_url":"https://academic.oup.com/neuro-oncology/article-pdf/20/suppl_6/vi77/26280134/noy148.314.pdf","source":{"id":"https://openalex.org/S106908163","display_name":"Neuro-Oncology","issn_l":"1522-8517","issn":["1522-8517","1523-5866"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neuro-Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://academic.oup.com/neuro-oncology/article-pdf/20/suppl_6/vi77/26280134/noy148.314.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5074432511","display_name":"Abigail Shelton","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Abigail Shelton","raw_affiliation_strings":["UNC Chapel Hill, Chapel Hill, NC, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"UNC Chapel Hill, Chapel Hill, NC, USA","institution_ids":["https://openalex.org/I114027177"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001036572","display_name":"Erin Smithberger","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Erin Smithberger","raw_affiliation_strings":["UNC Chapel Hill, Chapel Hill, NC, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"UNC Chapel Hill, Chapel Hill, NC, USA","institution_ids":["https://openalex.org/I114027177"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060315102","display_name":"Madison K. Butler","orcid":"https://orcid.org/0000-0002-1031-2054","observed_orcids":["https://orcid.org/0000-0002-1031-2054"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Madison Butler","raw_affiliation_strings":["NIH, Chapel Hill, NC, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"NIH, Chapel Hill, NC, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110918815","display_name":"\u00c1lex Flores","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Alex Flores","raw_affiliation_strings":["UNC Chapel Hill, Chapel Hill, NC, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"UNC Chapel Hill, Chapel Hill, NC, USA","institution_ids":["https://openalex.org/I114027177"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020249243","display_name":"Ryan Bash","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ryan Bash","raw_affiliation_strings":["UNC Chapel Hill, Chapel Hill, NC, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"UNC Chapel Hill, Chapel Hill, NC, USA","institution_ids":["https://openalex.org/I114027177"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5067366916","display_name":"Steven P. Angus","orcid":"https://orcid.org/0000-0002-7655-657X","observed_orcids":["https://orcid.org/0000-0002-7655-657X"]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Steven Angus","raw_affiliation_strings":["University of North Carolina School of Medicine, Department of Pharmacology, Chapel Hill, NC, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of North Carolina School of Medicine, Department of Pharmacology, Chapel Hill, NC, USA","institution_ids":["https://openalex.org/I114027177"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014356370","display_name":"Noah Sciaky","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Noah Sciaky","raw_affiliation_strings":["UNC Chapel Hill, Chapel Hill, NC, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"UNC Chapel Hill, Chapel Hill, NC, USA","institution_ids":["https://openalex.org/I114027177"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5031163794","display_name":"Harshil Dhruv","orcid":"https://orcid.org/0000-0003-2571-6649","observed_orcids":["https://orcid.org/0000-0003-2571-6649"]},"institutions":[{"id":"https://openalex.org/I1284308235","display_name":"Translational Genomics Research Institute","ror":"https://ror.org/02hfpnk21","country_code":"US","type":"facility","lineage":["https://openalex.org/I1284308235"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Harshil Dhruv","raw_affiliation_strings":["Translational Genomics Research Institute, Phoenix, AZ, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Translational Genomics Research Institute, Phoenix, AZ, USA","institution_ids":["https://openalex.org/I1284308235"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5047612906","display_name":"Gary L. Johnson","orcid":"https://orcid.org/0000-0003-2867-0551","observed_orcids":["https://orcid.org/0000-0003-2867-0551"]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Gary Johnson","raw_affiliation_strings":["University of North Carolina School of Medicine, Department of Pharmacology, Chapel Hill, NC, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of North Carolina School of Medicine, Department of Pharmacology, Chapel Hill, NC, USA","institution_ids":["https://openalex.org/I114027177"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055952981","display_name":"Michael E. Berens","orcid":"https://orcid.org/0000-0002-3382-6787","observed_orcids":["https://orcid.org/0000-0002-3382-6787"]},"institutions":[{"id":"https://openalex.org/I1284308235","display_name":"Translational Genomics Research Institute","ror":"https://ror.org/02hfpnk21","country_code":"US","type":"facility","lineage":["https://openalex.org/I1284308235"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Michael Berens","raw_affiliation_strings":["Translational Genomics Research Institute, Phoenix, AZ, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Translational Genomics Research Institute, Phoenix, AZ, USA","institution_ids":["https://openalex.org/I1284308235"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036985768","display_name":"Frank B. Furnari","orcid":"https://orcid.org/0000-0003-1909-4361","observed_orcids":["https://orcid.org/0000-0003-1909-4361"]},"institutions":[{"id":"https://openalex.org/I4210150094","display_name":"Ludwig Cancer Research","ror":"https://ror.org/05qdwtz81","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4210150094"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Frank Furnari","raw_affiliation_strings":["Ludwig Cancer Research, San Diego, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Ludwig Cancer Research, San Diego, CA, USA","institution_ids":["https://openalex.org/I4210150094"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5032063105","display_name":"C. Ryan Miller","orcid":"https://orcid.org/0000-0002-0096-8762","observed_orcids":["https://orcid.org/0000-0002-0096-8762"]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ryan Miller","raw_affiliation_strings":["UNC Chapel Hill, Chapel Hill, NC, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"UNC Chapel Hill, Chapel Hill, NC, USA","institution_ids":["https://openalex.org/I114027177"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":5132,"currency":"USD","value_usd":5132},"apc_paid":null,"fwci":null,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"20","issue":"suppl_6","first_page":"vi77","last_page":"vi77"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10129","display_name":"Glioma Diagnosis and Treatment","score":0.9146000146865845,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10129","display_name":"Glioma Diagnosis and Treatment","score":0.9146000146865845,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":0.0617000013589859,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","score":0.004900000058114529,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/glioblastoma","display_name":"glioblastoma","score":0.9909999966621399},{"id":"https://openalex.org/keywords/egfrviii","display_name":"EGFRvIII","score":0.7760000228881836},{"id":"https://openalex.org/keywords/tyrosine-kinase-inhibitors","display_name":"tyrosine kinase inhibitors","score":0.9039999842643738},{"id":"https://openalex.org/keywords/acquired-drug-resistance","display_name":"acquired drug resistance","score":0.9369999766349792},{"id":"https://openalex.org/keywords/gefitinib","display_name":"gefitinib","score":0.9309999942779541},{"id":"https://openalex.org/keywords/erlotinib","display_name":"erlotinib","score":1.0},{"id":"https://openalex.org/keywords/cross-resistance","display_name":"cross-resistance","score":0.6850000023841858},{"id":"https://openalex.org/keywords/kinome-reprogramming","display_name":"kinome reprogramming","score":0.8360000252723694},{"id":"https://openalex.org/keywords/cdkn2a-deletion","display_name":"CDKN2A deletion","score":0.8299999833106995},{"id":"https://openalex.org/keywords/transcriptomic-changes","display_name":"transcriptomic changes","score":0.5580000281333923},{"id":"https://openalex.org/keywords/blood-brain-barrier-penetration","display_name":"blood-brain barrier penetration","score":0.6190000176429749},{"id":"https://openalex.org/keywords/therapeutic-target","display_name":"therapeutic target","score":0.6119999885559082}],"concepts":[{"id":"https://openalex.org/C54174078","wikidata":"https://www.wikidata.org/wiki/Q3197188","display_name":"Kinome","level":3,"score":0.9524266719818115},{"id":"https://openalex.org/C2780580887","wikidata":"https://www.wikidata.org/wiki/Q417824","display_name":"Gefitinib","level":4,"score":0.8252848386764526},{"id":"https://openalex.org/C2778087573","wikidata":"https://www.wikidata.org/wiki/Q418369","display_name":"Erlotinib","level":4,"score":0.7317386865615845},{"id":"https://openalex.org/C2780265364","wikidata":"https://www.wikidata.org/wiki/Q5009957","display_name":"CDKN2A","level":3,"score":0.6131046414375305},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.6108906269073486},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.5477872490882874},{"id":"https://openalex.org/C2777506169","wikidata":"https://www.wikidata.org/wiki/Q424401","display_name":"EGFR inhibitors","level":4,"score":0.5369439125061035},{"id":"https://openalex.org/C162317418","wikidata":"https://www.wikidata.org/wiki/Q252857","display_name":"Transcriptome","level":4,"score":0.46049264073371887},{"id":"https://openalex.org/C2778820342","wikidata":"https://www.wikidata.org/wiki/Q906415","display_name":"Tyrosine-kinase inhibitor","level":3,"score":0.4515296220779419},{"id":"https://openalex.org/C42362537","wikidata":"https://www.wikidata.org/wiki/Q87099740","display_name":"Tyrosine kinase","level":3,"score":0.4479828476905823},{"id":"https://openalex.org/C2779438470","wikidata":"https://www.wikidata.org/wiki/Q424401","display_name":"Epidermal growth factor receptor","level":3,"score":0.341085284948349},{"id":"https://openalex.org/C184235292","wikidata":"https://www.wikidata.org/wiki/Q421851","display_name":"Kinase","level":2,"score":0.33378350734710693},{"id":"https://openalex.org/C62478195","wikidata":"https://www.wikidata.org/wiki/Q828130","display_name":"Signal transduction","level":2,"score":0.24537009000778198},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.18220946192741394},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.17120468616485596},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.141184002161026},{"id":"https://openalex.org/C150194340","wikidata":"https://www.wikidata.org/wiki/Q26972","display_name":"Gene expression","level":3,"score":0.08205068111419678}],"mesh":[],"locations_count":3,"locations":[{"id":"doi:10.1093/neuonc/noy148.314","doi":"https://doi.org/10.1093/neuonc/noy148.314","is_oa":true,"landing_page_url":"https://doi.org/10.1093/neuonc/noy148.314","pdf_url":"https://academic.oup.com/neuro-oncology/article-pdf/20/suppl_6/vi77/26280134/noy148.314.pdf","source":{"id":"https://openalex.org/S106908163","display_name":"Neuro-Oncology","issn_l":"1522-8517","issn":["1522-8517","1523-5866"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neuro-Oncology","raw_type":"journal-article"},{"id":"pmh:oai:europepmc.org:5785888","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/6216447","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":null,"raw_type":"Text"},{"id":"pmh:oai:pubmedcentral.nih.gov:6216447","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/6216447","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neuro Oncol","raw_type":"Text"}],"best_oa_location":{"id":"doi:10.1093/neuonc/noy148.314","doi":"https://doi.org/10.1093/neuonc/noy148.314","is_oa":true,"landing_page_url":"https://doi.org/10.1093/neuonc/noy148.314","pdf_url":"https://academic.oup.com/neuro-oncology/article-pdf/20/suppl_6/vi77/26280134/noy148.314.pdf","source":{"id":"https://openalex.org/S106908163","display_name":"Neuro-Oncology","issn_l":"1522-8517","issn":["1522-8517","1523-5866"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neuro-Oncology","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9763000011444092,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2899834042.pdf","grobid_xml":"https://content.openalex.org/works/W2899834042.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4235969460","https://openalex.org/W3112265682","https://openalex.org/W2987346895","https://openalex.org/W4282962539","https://openalex.org/W2899724292","https://openalex.org/W4282926448","https://openalex.org/W2955618965","https://openalex.org/W2041407095","https://openalex.org/W2053331611","https://openalex.org/W4282984091"],"abstract_inverted_index":{"Glioblastoma":[0],"(GBM),":[1],"the":[2,46,98,114,191,198,210,290],"most":[3,47],"common":[4],"and":[5,26,38,56,77,126,148,183,193,245,260],"malignant":[6],"adult":[7],"primary":[8],"brain":[9],"tumor,":[10],"has":[11],"been":[12],"extensively":[13],"molecularly":[14],"characterized.":[15],"Two":[16],"mutations":[17,55],"occur":[18,264],"at":[19],"particularly":[20],"high":[21],"frequency:":[22],"CDKN2A":[23],"deletion":[24],"(50\u201360%)":[25],"EGFR":[27,44,115],"(40\u201350%),":[28],"especially":[29],"EGFRvIII":[30,100],"(~35%)":[31],"in":[32,40,73,124,127,190,196,224,243,246,265],"which":[33],"exons":[34],"2\u20137":[35],"are":[36,85,174,215],"deleted":[37],"result":[39],"constitutive":[41],"kinase":[42,66],"activation.":[43],"is":[45],"attractive":[48],"therapeutic":[49,284],"target":[50],"due":[51,72],"to":[52,75,113,143,154,187,208,220,226,280],"frequent":[53],"activating":[54,99],"ready":[57],"availability":[58],"of":[59,93,140,146,202,204,258,268,294],"multiple":[60],"targeted":[61],"inhibitors.":[62],"Several":[63],"EGFR-targeted":[64],"tyrosine":[65],"inhibitors":[67],"(TKI)":[68],"have":[69,159],"failed":[70],"clinically,":[71],"part":[74],"intrinsic":[76],"acquired":[78,105],"resistance.":[79,171],"To":[80,103],"examine":[81,188],"these":[82,227,252],"mechanisms,":[83],"we":[84,173,214],"using":[86,175],"genetically-engineered":[87],"mouse":[88,236],"astrocytes":[89,108,237],"harboring":[90],"homozygous":[91],"deletions":[92],"Cdkn2a,":[94],"as":[95,97],"well":[96],"mutation":[101],"(CEv3).":[102],"model":[104],"resistance,":[106],"CEv3":[107,235],"were":[109],"made":[110],"intrinsically":[111],"resistant":[112,234],"TKI":[116,170],"gefitinib":[117,133],"or":[118,134,200],"erlotinib":[119,135],"via":[120],"long-term":[121,132],"exposure,":[122],"both":[123,197],"vitro":[125,244],"vivo.":[128],"We":[129,158],"found":[130],"that":[131,162,233,263,286],"exposure":[136],"confers":[137],"variable":[138],"levels":[139],"cross":[141],"resistance":[142],"a":[144,176,256],"panel":[145],"second-":[147],"third-generation":[149],"EGFR-TKI":[150,206],"(\u0394IC50":[151],"1.12-36.1-fold),":[152],"relative":[153],"non-resistant":[155,242],"parent":[156],"lines.":[157],"previously":[160],"shown":[161],"dynamic":[163],"kinome":[164],"reprogramming":[165],"may":[166],"be":[167,278],"responsible":[168],"for":[169],"Therefore,":[172],"chemical":[177],"proteomics":[178],"method,":[179],"multiplexed":[180],"inhibitor":[181],"beads":[182],"mass":[184],"spectrometry":[185],"(MIB-MS),":[186],"changes":[189,262],"expressed":[192],"functional":[194],"kinome,":[195],"presence":[199],"absence":[201],"one":[203],"several":[205],"known":[207],"penetrate":[209],"blood-brain":[211],"barrier.":[212],"Additionally,":[213],"performing":[216],"RNA":[217],"sequencing":[218],"(RNA-seq)":[219],"inspect":[221],"transcriptomic":[222,259],"alterations":[223],"response":[225],"drugs.":[228],"Preliminary":[229],"RNA-seq":[230],"results":[231],"showed":[232],"clustered":[238],"separately":[239],"from":[240,251],"their":[241],"vivo":[247],"counterparts.":[248],"Together,":[249],"data":[250],"experiments":[253],"will":[254],"create":[255],"framework":[257,275],"proteomic":[261],"murine":[266],"models":[267],"GBM":[269],"with":[270],"defined":[271],"mutational":[272],"profiles.":[273],"This":[274],"can":[276],"then":[277],"used":[279],"help":[281],"define":[282],"novel":[283],"targets":[285],"could":[287],"significantly":[288],"alter":[289],"current":[291],"treatment":[292],"paradigm":[293],"GBM.":[295]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2018-11-16T00:00:00"}